PAREXEL International Named A FlexJobs Top 100 Company To Watch For Telecommuting Jobs In 2016

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting Jobs in 2016 for the third consecutive year. The list recognizes companies with a telecommuting-friendly component to some of their jobs, such as the ability to telecommute entirely or part of the time.

“PAREXEL is a forward-thinking company that understands that offering telecommuting options is a smart business strategy”

PAREXEL offers approximately 20 percent of its global employees flexible work options, including telecommuting, flexible schedules, and home-based employment. In North America, approximately 40 percent of PAREXEL’s employees take advantage of the Company’s telecommuting and flexible work opportunities. These employees represent a diverse cross section of positions, including clinical research, biostatistics, and regulatory affairs.

“Giving employees telecommuting opportunities and flexible work options has opened the door for us to find the best and the brightest talent in the industry. Recruiting the best talent helps to ensure that we can deliver for our clients,” said Tom McGoldrick, Vice President of Talent Acquisition, PAREXEL. “PAREXEL’s varied work options also provide access to a skilled labor force without geographic restrictions, which is important for meeting organizational growth and helping our clients simplify their journey towards bringing new treatments to the patients who need them around the world.”

PAREXEL has a dedicated “Decentralized Employees Support Community” on the Company Intranet. The community includes recommendations for collaboration tools to help employees connect with each other and advice on setting up a home office. PAREXEL also offers several training programs for home-based employees.

“PAREXEL is a forward-thinking company that understands that offering telecommuting options is a smart business strategy,” said Sara Sutton Fell, founder and CEO of FlexJobs. “Telecommuting can benefit companies in so many ways, including cost savings, increased productivity and retention, better candidate pools, enriched company culture, and improved employee health.”

About the Ranking
FlexJobs, a job service specializing in remote and flexible job opportunities, analyzed its database of more than 40,000 companies’ job posting history in 2015 to determine which companies would be most likely to incorporate telecommuting into their hiring practices in 2016. To be considered, companies had to offer a telecommuting-friendly component to some of their jobs, such as an arrangement to telecommute entirely, part of the time, or as an option. In 2016, PAREXEL ranked 18th in the top 100.

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 77 locations in 51 countries around the world, and had approximately 18,200 employees in the second quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation. All other trademarks are the property of their respective owners.

This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “will,” “would,” “could,” “should,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. Such factors and others are discussed in the section entitled “Risk Factors” of the Company’s most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission, which “Risk Factors” discussion is incorporated by reference in this press release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.